"Avoidable Deaths" - Union for International Cancer Control

"Back to Basics: The Concept of HRQL Under a Magnifying Glass" - EORTC Quality of Life Group

"Bald for a Cause" initiative - UWC Dilijan College

Freddy Nguyen: CancerX Reception at The City Club of San Francisco

Jarushka Naidoo: Third neoadjuvant FDA approval in NSCLC

Highlights From Bladder Cancer Advocacy Network Think Tank 2025 by Shilpa Gupta

Fredrik Schjesvold: CAR-T for Myeloma is Now Approved in Sweden

ASCO24 Updates: Dr. Patricia Keegan on Neoadjuvant Chemotherapy for Gastric Cancer with Toripalimab

Carmen Monge-Montero: Alma Seidel shares an insight for parents navigating the emotional weight of childhood cancer

Vivek Subbiah

Sep 7, 2023

Insight

Vivek Subbiah: Super delighted to Join Dr. Stephen V Liu to share my thoughts…

Sep 7, 2023

Positive

Vivek Subbiah: Keep taking steps forward, even if it feels impossible to turn back.

Sep 5, 2023

Insight

Vivek Subbiah: Give the right drug, to the right patient, at the right time in every country, to think globally and act locally.

Aug 31, 2023

Insight

Vivek Subbiah: The evidence for different approaches to colorectal cancer screening is reviewed and a framework for evaluation of screening programs going forward is proposed.

Aug 30, 2023

Insight

Vivek Subbiah: Adding chemotherapy to cemiplimab at progression might provide a new second-line treatment for patients with advanced non-small-cell lung cancer.

Aug 28, 2023

Insight

Vivek Subbiah: Lurbinectedin was approved for Small cell Lung in USA and now is also approved in Canada, Australia, Singapore, the United Arab Emirates, Qatar, South Korea, Ecuador, Mexico, Israel and Switzerland.

Aug 27, 2023